Winkelman Dillon, Smith-Gagen Julie, Rebholz Casey M, Gutierrez Orlando M, St-Jules David E
Department of Environmental Science and Health, University of Nevada, Reno, Nevada.
School of Public Health, University of Nevada, Reno, Nevada.
Clin J Am Soc Nephrol. 2024 Nov 1;19(11):1435-1443. doi: 10.2215/CJN.0000000000000538. Epub 2024 Aug 14.
Intake of whole grains was not associated with CKD mineral and bone disorder biomarkers. Intake of whole grains in relation to refined grains was associated with lower risk of cardiovascular disease, kidney failure, and mortality. The restriction of whole grains among people with CKD may be unwarranted.
Patients with CKD are encouraged to choose refined grains instead of whole grains as part of the low-phosphorus diet for managing CKD-mineral and bone disorders (CKD-MBD). However, there is no direct evidence indicating that limiting whole grains has a beneficial impact on CKD outcomes.
This study analyzed Chronic Renal Insufficiency Cohort data in two ways, namely cross-sectional examination of CKD-MBD biomarkers and prospective examination of health outcomes. A total of 4067 (cross-sectional) and 4331 (prospective) participants were included. The primary exposure was reported intake of whole grains (analyzed as servings/d, servings/1,000 kcal, and refined grain servings/whole grain servings). CKD-MBD biomarkers included serum phosphorus, fibroblast growth factor-23, parathyroid hormone, calcitriol, and calcium. Outcomes included cardiovascular events, kidney failure, and all-cause mortality.
In adjusted models, reported intake of whole grains was associated with higher phosphorus intake and serum phosphorus when assessed crudely (serving/d), but not when analyzed in relation to energy. Higher intake of refined grain relative to whole grains was associated (all models) with higher risk of kidney failure (model 4: 1.01; 95% confidence interval, 1.00 to 1.02; = 0.01, all-cause mortality (model 4: 1.01; 95% confidence interval, 1.00 to 1.01; = 0.01), and cardiovascular disease except for the fully adjusted model. Higher dietary density was associated with lower mortality in models adjusted for demographic and clinical factors including kidney function, but not in the fully adjusted model that further adjusted for dietary factors.
Intake of whole grains was not associated with CKD-MBD biomarkers. Intake of whole grains in relation to refined grains was associated with lower risk of cardiovascular disease, kidney failure, and mortality. The results of this study put into question the long-standing practice of restricting whole grains in patients with CKD.
全谷物的摄入量与慢性肾脏病矿物质和骨异常生物标志物无关。与精制谷物相比,全谷物的摄入与较低的心血管疾病、肾衰竭和死亡风险相关。对慢性肾脏病患者限制全谷物摄入可能没有必要。
鼓励慢性肾脏病患者选择精制谷物而非全谷物,作为低磷饮食的一部分来管理慢性肾脏病矿物质和骨异常(CKD-MBD)。然而,没有直接证据表明限制全谷物对慢性肾脏病的预后有有益影响。
本研究通过两种方式分析慢性肾功能不全队列数据,即对CKD-MBD生物标志物进行横断面检查以及对健康结局进行前瞻性检查。共纳入4067名(横断面)和4331名(前瞻性)参与者。主要暴露因素为报告的全谷物摄入量(分析为份数/天、份数/1000千卡以及精制谷物份数/全谷物份数)。CKD-MBD生物标志物包括血清磷、成纤维细胞生长因子-23、甲状旁腺激素、骨化三醇和钙。结局包括心血管事件、肾衰竭和全因死亡率。
在调整模型中,粗略评估(份数/天)时,报告的全谷物摄入量与较高的磷摄入量和血清磷相关,但按能量分析时则不然。相对于全谷物,较高的精制谷物摄入量(所有模型)与较高的肾衰竭风险相关(模型4:1.01;95%置信区间,1.00至1.02;P = 0.01)、全因死亡率(模型4:1.01;95%置信区间,1.00至1.01;P = 0.01),除完全调整模型外,还与心血管疾病相关。在针对包括肾功能在内的人口统计学和临床因素进行调整的模型中,较高的饮食密度与较低的死亡率相关,但在进一步针对饮食因素进行调整的完全调整模型中则不然。
全谷物的摄入量与CKD-MBD生物标志物无关。与精制谷物相比,全谷物的摄入与较低的心血管疾病、肾衰竭和死亡风险相关。本研究结果对长期以来对慢性肾脏病患者限制全谷物摄入的做法提出了质疑。